Scale -

  • Ebitda is 3.73 Rs Cr; Annual Growth is 222 %; 5 Year CAGR is 26 %; in Bottom Quartile
  • PBT is 0.13 Rs Cr; Annual Growth is 366 %; 5 Year CAGR is 36 %; in Bottom Quartile
  • PAT is 2.79 Rs Cr; Annual Growth is 398 %; 5 Year CAGR is 41 %
  • Quarterly Revenue is 12.35 Rs Cr; Continuous Growth over 3 Quarters; in Bottom Quartile
  • Revenue is 28.4 Rs Cr; Continuous Decline over 3 years; in Bottom Quartile
  • Quarterly Ebitda is 0.14 Rs Cr; in Bottom Quartile

Profitability -

  • PBDIT Margin is 13.14 %; Annual Growth is 281 %; Continuous Growth over 3 years; 5 Year CAGR is 19 %
  • PAT Margin is 9.81 %; Annual Growth is 491 %; 5 Year CAGR is 33 %
  • Quarterly Ebitda Margin is 1 %; Continuous Decline over 3 Quarters; in Bottom Quartile
  • Quarterly Profit margin is 1 %; Continuous Decline over 3 Quarters; in Bottom Quartile

Return -

  • ROCE is 15.61 %; Annual Growth is 286 %; 5 Year CAGR is 26 %
  • ROA is 6.5 %; Annual Growth is 496 %
  • ROE is 12.91 %; Annual Growth is 336 %; 5 Year CAGR is 33 %
  • Asset Turnover is 61 %; Continuous Decline over 3 years

Efficiency -

  • Operating cash flow is -0.6 Rs Cr; Annual Growth is 69 %; in Bottom Quartile
  • Inventory Turnover Ratio is 7.74; in Top Quartile; 5 Year CAGR is 76 %; Annual Decline is -32 %
  • Current Ratio is 1.73; 5 Year CAGR is -27 %
  • Quick Ratio is 1.54; 5 Year CAGR is -27 %

Solvancy -

  • Total Debt is 3.02 Rs Cr; in Bottom Quartile; Annual Growth is 543 %; Continuous Growth over 3 years; 5 Year CAGR is 60 %
  • Contingent Liabilities is 0 Rs Cr; in Bottom Quartile
  • Debt/Equity is 0.14; Annual Growth is 367 %; Continuous Growth over 3 years; 5 Year CAGR is 47 %

Quality -

  • Operating cashflow/ebitda is -16 %; Annual Growth is 90 %; in Bottom Quartile
  • Operating cashflow/PAT is -22 %; Annual Growth is 94 %; in Bottom Quartile
  • Current Tax/PAT is 15 %; Annual Decline is -61 %; 5 Year CAGR is -21 %
  • Other Expenses/Total Expenses is 4 %; in Bottom Quartile; Continuous Growth over 3 years
  • Change in Inventories/Total Expenses is -1 %; Annual Growth is 72 %
  • Exceptional Items/PBT is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector
Major Subsidiaries/Associates
Key Clients

Products

Products
Product details

Operations

Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Biofil Chemicals & Pharmaceuticals (BIOFILCHEM.NS) Steadies Near ?30 as Support Zone Comes Into Focus
Read More
  • Past/current